| scholarly article | Q13442814 |
| P50 | author | Barton Haynes | Q4865631 |
| Michael Saag | Q6834090 | ||
| Myron S. Cohen | Q16733099 | ||
| Bette Korber | Q30505218 | ||
| Alan S. Perelson | Q55719625 | ||
| Nicholas F Parrish | Q56771203 | ||
| Jesus F Salazar-Gonzalez | Q57415418 | ||
| Brandon Keele | Q68690678 | ||
| George M. Shaw | Q78514357 | ||
| John C Kappes | Q92482518 | ||
| Cynthia A Derdeyn | Q94562588 | ||
| Katharine J Bar | Q102210398 | ||
| Joshua Baalwa | Q114512825 | ||
| Katharina S Shaw | Q114512827 | ||
| Elena E Giorgi | Q122828494 | ||
| Joseph Mulenga | Q122828500 | ||
| Christina Ochsenbauer-Jambor | Q125314401 | ||
| M Brad Guffey | Q125314582 | ||
| Peter T. Hraber | Q37366689 | ||
| Gerald H Learn | Q54541884 | ||
| Beatrice H. Hahn | Q55293537 | ||
| Tanmoy Bhattacharya | Q55414889 | ||
| P2093 | author name string | Hui Li | |
| Martin Markowitz | |||
| Susan Allen | |||
| Matthias H Kraus | |||
| Eric Hunter | |||
| Shuyi Wang | |||
| Julie M Decker | |||
| Maria G Salazar | |||
| Katie L Davis | |||
| P2860 | cites work | HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC | Q21559422 |
| CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
| Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract | Q22242981 | ||
| Transmission, acute HIV-1 infection and the quest for strategies to prevent infection | Q22251056 | ||
| CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
| Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola | Q24548936 | ||
| Viral Sequence Evolution in Acute Hepatitis C Virus Infection | Q27484985 | ||
| Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus | Q28302762 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
| Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
| Rapid evolution of the neutralizing antibody response to HIV type 1 infection | Q29618603 | ||
| Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | Q29619015 | ||
| Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection | Q29619099 | ||
| Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection | Q29619124 | ||
| Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. | Q29619254 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase | Q29619994 | ||
| Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1 | Q33402461 | ||
| Clinical picture of primary HIV infection presenting as a glandular-fever-like illness | Q33447605 | ||
| Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis | Q33881912 | ||
| Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines | Q33911935 | ||
| Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
| Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis. | Q34717126 | ||
| Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group | Q64130059 | ||
| Clinical and epidemiologic features of primary HIV infection | Q71182378 | ||
| A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo | Q34858885 | ||
| The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. | Q35062297 | ||
| Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa | Q35140032 | ||
| Inhibiting sexual transmission of HIV-1 infection | Q35709090 | ||
| Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. | Q35830147 | ||
| Rabies virus quasispecies: implications for pathogenesis | Q35980649 | ||
| Perils at mucosal front lines for HIV and SIV and their hosts | Q36274922 | ||
| Viral dynamics of acute HIV-1 infection | Q36375339 | ||
| Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response | Q36399559 | ||
| Antigenic conservation and immunogenicity of the HIV coreceptor binding site | Q36403587 | ||
| Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? | Q36422860 | ||
| Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing | Q36540055 | ||
| Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection | Q36647820 | ||
| Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma | Q37051645 | ||
| Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. | Q37110723 | ||
| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants | Q37145228 | ||
| Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. | Q37273086 | ||
| The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection | Q37273195 | ||
| High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination | Q37471315 | ||
| Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes | Q38979142 | ||
| Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo | Q39588498 | ||
| Blood monocytes harbor HIV type 1 strains with diversified phenotypes including macrophage-specific CCR5 virus | Q39609207 | ||
| Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity | Q40982856 | ||
| Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection | Q45738778 | ||
| Modeling plasma virus concentration during primary HIV infection | Q45743854 | ||
| High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection | Q45854355 | ||
| Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group. | Q52070829 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| phenotype | Q104053 | ||
| HIV transmission | Q49029021 | ||
| P304 | page(s) | 1273-1289 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | |
| P478 | volume | 206 |
| Q55383445 | A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge. |
| Q46297514 | A Variance-Components Model for Distance-Matrix PhylogeneticReconstruction. |
| Q33825756 | A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa |
| Q35783015 | A critical question for HIV vaccine development: which antibodies to induce? |
| Q27024614 | A global approach to HIV-1 vaccine development |
| Q33966648 | A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. |
| Q90066250 | A new cell line for assessing HIV-1 antibody dependent cellular cytotoxicity against a broad range of variants |
| Q36363866 | A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays |
| Q37410812 | A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains |
| Q33653774 | A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays |
| Q94947217 | A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting |
| Q36337888 | Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model. |
| Q30359547 | Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release |
| Q34185814 | Acute HIV-1 Infection |
| Q58038022 | Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level |
| Q36667979 | Adaptation to the interferon-induced antiviral state by human and simian immunodeficiency viruses |
| Q33961448 | Adoption of an "open" envelope conformation facilitating CD4 binding and structural remodeling precedes coreceptor switch in R5 SHIV-infected macaques |
| Q47548907 | Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations. |
| Q35077677 | An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum |
| Q42038291 | An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. |
| Q30781299 | An evaluation of phylogenetic methods for reconstructing transmitted HIV variants using longitudinal clonal HIV sequence data |
| Q55516259 | An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development. |
| Q33627673 | Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies |
| Q55562325 | Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid. |
| Q28081831 | Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis |
| Q35689392 | Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors |
| Q36164165 | Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission |
| Q47146547 | Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission? |
| Q92226023 | Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection |
| Q34728767 | BAsE-Seq: a method for obtaining long viral haplotypes from short sequence reads |
| Q37254470 | BLT humanized mice as model to study HIV vaginal transmission |
| Q35140968 | Barriers to mucosal transmission of immunodeficiency viruses |
| Q28082862 | Bottlenecks in HIV-1 transmission: insights from the study of founder viruses |
| Q39451862 | Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection |
| Q37397841 | Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission |
| Q36742476 | CCR5 interaction with HIV-1 Env contributes to Env-induced depletion of CD4 T cells in vitro and in vivo. |
| Q92524713 | CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection |
| Q30432007 | CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesis |
| Q89686737 | CD8+ T cells in HIV control, cure and prevention |
| Q34291056 | Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells |
| Q38154038 | Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies |
| Q34539781 | Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children |
| Q36376213 | Central nervous system viral invasion and inflammation during acute HIV infection |
| Q34720281 | Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient |
| Q40393973 | Characterization of founder viruses in very early SIV rectal transmission |
| Q35140429 | Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry |
| Q34053295 | Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtained |
| Q38721805 | Characterizing HIV-1 Splicing by Using Next-Generation Sequencing |
| Q37841429 | Chemokine-mediated immune responses in the female genital tract mucosa |
| Q90134557 | Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies |
| Q27691426 | Clinical significance of HIV-1 coreceptor usage |
| Q37152155 | Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis |
| Q54251489 | Clonal interference can cause wavelet-like oscillations of multilocus linkage disequilibrium. |
| Q36978861 | Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design |
| Q35219829 | Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection |
| Q41610618 | Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains |
| Q57796335 | Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth |
| Q35488153 | Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission |
| Q36288959 | Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process |
| Q33857491 | Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry |
| Q35826200 | Contribution of intra- and interhost dynamics to norovirus evolution |
| Q59358243 | Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses |
| Q35330357 | Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms |
| Q57468964 | Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs |
| Q90859869 | Cyclophilin A protects HIV-1 from restriction by human TRIM5α |
| Q34413887 | De novo assembly of highly diverse viral populations |
| Q35140263 | Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes |
| Q37252894 | Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection |
| Q36885187 | Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies |
| Q33951977 | Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing |
| Q36736392 | Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques |
| Q33922689 | Development of a contemporary globally diverse HIV viral panel by the EQAPOL program |
| Q34535266 | Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses |
| Q28551914 | Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus |
| Q36343848 | Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction. |
| Q33827798 | Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production |
| Q30360141 | Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses. |
| Q36277153 | Differentiating founder and chronic HIV envelope sequences. |
| Q42276242 | Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. |
| Q60952499 | Disparate impact on CD4 T cell count by two distinct HIV-1 phylogenetic clusters from the same clade |
| Q34503200 | Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies |
| Q36414547 | Distinct evolutionary pressures underlie diversity in simian immunodeficiency virus and human immunodeficiency virus lineages |
| Q34315382 | Diversity of envelope genes from an uncloned stock of SIVmac251. |
| Q40040133 | Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation. |
| Q35168379 | Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR. |
| Q42251857 | Dynamics of in vitro fitness recovery of HIV-1. |
| Q36000736 | Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape |
| Q46046314 | Early sites of virus replication after oral SIVmac251 infection of infant macaques: implications for pathogenesis |
| Q37252793 | Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells |
| Q92772993 | Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo |
| Q35799147 | Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression |
| Q39314021 | Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism |
| Q63246643 | Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA |
| Q36754296 | Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques |
| Q27329126 | Elimination of HIV-1-infected cells by broadly neutralizing antibodies |
| Q28482493 | Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing |
| Q38979760 | Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12. |
| Q37312719 | Enhancement of viral escape in HIV-1 Nef by STEP vaccination |
| Q40448856 | Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies. |
| Q91802349 | Envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in HIV-1 subtype C infection |
| Q37021717 | Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques |
| Q34804767 | Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection |
| Q33727328 | Estimating time since infection in early homogeneous HIV-1 samples using a poisson model |
| Q36095984 | Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality |
| Q34193198 | Evaluation of cervical mucosa in transmission bottleneck during acute HIV-1 infection using a cervical tissue-based organ culture |
| Q34819651 | Evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies over the course of the epidemic |
| Q33676640 | Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model |
| Q58794804 | Evolutionary view of the AIDS process |
| Q33916640 | Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. |
| Q36111516 | Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1 |
| Q33602718 | Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild |
| Q42239239 | Fitness valleys constrain HIV-1's adaptation to its secondary chemokine coreceptor. |
| Q36945699 | Future of phylogeny in HIV prevention |
| Q35629509 | GSK1265744 demonstrates robust in vitro activity against various clades of HIV-1. |
| Q59358201 | Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques |
| Q35748138 | Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides |
| Q35115599 | Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocks |
| Q35826158 | Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages |
| Q45325228 | Genetic bottlenecks in intraspecies virus transmission |
| Q34290999 | Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys |
| Q33838382 | Genital tract sequestration of SIV following acute infection |
| Q36909871 | Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men Who Have Sex with Men in Northeastern China |
| Q36601113 | Genome Sequences of a Novel HIV-1 Circulating Recombinant Form, CRF55_01B, Identified in China |
| Q35289861 | Genotypic and functional properties of early infant HIV-1 envelopes |
| Q37460075 | Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C. |
| Q35110503 | Giant cell encephalitis and microglial infection with mucosally transmitted simian-human immunodeficiency virus SHIVSF162P3N in rhesus macaques |
| Q28265115 | Glycans, galectins, and HIV-1 infection |
| Q47555792 | Glycosyl-phosphatidylinositol-Anchored Anti-HIV Env Single Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity |
| Q40174150 | Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin. |
| Q36155024 | Glycosylation of simian immunodeficiency virus influences immune-tissue targeting during primary infection, leading to immunodeficiency or viral control |
| Q33967039 | Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. |
| Q37771138 | HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals |
| Q39520219 | HIV pre-exposure prophylaxis for women and infants prevents vaginal and oral HIV transmission in a preclinical model of HIV infection |
| Q28475647 | HIV promoter integration site primarily modulates transcriptional burst size rather than frequency |
| Q42212831 | HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences |
| Q37853935 | HIV sexual transmission and microbicides |
| Q36526615 | HIV transmission |
| Q36269097 | HIV transmission biology: translation for HIV prevention |
| Q34906292 | HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck |
| Q34342558 | HIV vaccines: lessons learned and the way forward |
| Q45378201 | HIV vaccines: mosaic approach to virus diversity |
| Q37851950 | HIV vaccines: progress to date. |
| Q36022372 | HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients |
| Q35995791 | HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity |
| Q35260218 | HIV-1 Subtype C Phylodynamics in the Global Epidemic |
| Q37287774 | HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells |
| Q35067233 | HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo |
| Q38718438 | HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4+ T Cells by NK Cells |
| Q36997294 | HIV-1 Vpu Mediates HLA-C Downregulation |
| Q35895988 | HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins |
| Q45323939 | HIV-1 and Hepatitis C virus selection bottleneck in Chinese people who inject drugs |
| Q55967625 | HIV-1 and the macrophage |
| Q27497560 | HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV |
| Q26825087 | HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies |
| Q34510531 | HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivo |
| Q91887203 | HIV-1 is more dependent on the K182 capsid residue than HIV-2 for interactions with CPSF6 |
| Q35216488 | HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages |
| Q36526530 | HIV-1 pathogenesis: the virus |
| Q34050421 | HIV-1 replication in the central nervous system occurs in two distinct cell types. |
| Q35215387 | HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model. |
| Q35196509 | HIV-1 target cells in the CNS. |
| Q35897398 | HIV-1 vaginal transmission: cell-free or cell-associated virus? |
| Q36767899 | HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection. |
| Q33753950 | HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins |
| Q37962420 | HIV/AIDS: 30 years of progress and future challenges. |
| Q35753766 | HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses. |
| Q33877425 | Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. |
| Q60947056 | Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4 T Cell Migration and Is Regulated by the Viral Immediate-Early Protein ICP4 |
| Q36827377 | Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock |
| Q35778333 | Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance |
| Q33582135 | High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. |
| Q35188022 | High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection |
| Q28533522 | High prevalence of HIV-1 intersubtype B'/C recombinants among injecting drug users in Dehong, China |
| Q34115280 | High viral fitness during acute HIV-1 infection |
| Q30570557 | High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. |
| Q47551736 | Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection. |
| Q59357225 | Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1 |
| Q21131400 | Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice |
| Q34486236 | Human immature Langerhans cells restrict CXCR4-using HIV-1 transmission |
| Q30404393 | Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review |
| Q34407843 | Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection |
| Q30424366 | Human immunodeficiency virus vaccine trials |
| Q36702615 | Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time |
| Q35192955 | Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes |
| Q33624872 | Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women |
| Q97523157 | Hypoxic microenvironment shapes HIV-1 replication and latency |
| Q36023199 | Identical consensus sequence and conserved genomic polymorphism of hepatitis E virus during controlled interspecies transmission |
| Q39615794 | Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques. |
| Q36484034 | Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques |
| Q35172385 | Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4 |
| Q34038460 | Identifying and characterizing recently transmitted viruses |
| Q37644009 | Identifying recombination hot spots in the HIV-1 genome |
| Q57007956 | Immune Dysfunction and Coinfection with Human Immunodeficiency Virus and in Yi People |
| Q35855904 | Immune evasion activities of accessory proteins Vpu, Nef and Vif are conserved in acute and chronic HIV-1 infection. |
| Q37789347 | Immune responses to HIV vaccines and potential impact on control of acute HIV-1 infection |
| Q35798108 | Immune-mediated attenuation of HIV-1 |
| Q59098671 | Immunology and the elusive AIDS vaccine |
| Q36394656 | Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome |
| Q28481938 | Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection |
| Q36495198 | Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay |
| Q36984267 | Impact of pre-adapted HIV transmission. |
| Q28477088 | Implications of CTL-mediated killing of HIV-infected cells during the non-productive stage of infection |
| Q36978467 | Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy |
| Q98906744 | Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide |
| Q38009870 | Improved outlook on HIV-1 prevention and vaccine development |
| Q35996364 | Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue. |
| Q47601205 | Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime-boost immunization |
| Q35694015 | Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. |
| Q34985572 | Inferring HIV Escape Rates from Multi-Locus Genotype Data |
| Q35861276 | Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission |
| Q36086631 | Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication |
| Q36637034 | Innate and adaptive anti-HIV immune responses in the female reproductive tract |
| Q38170229 | Innate antiviral immune signaling, viral evasion and modulation by HIV-1. |
| Q38139934 | Innate immune evasion strategies by human immunodeficiency virus type 1. |
| Q33997880 | Innate immune recognition and activation during HIV infection |
| Q59357124 | Interaction Between Macrophage Migration Inhibitory Factor and CD74 in Human Immunodeficiency Virus Type I Infected Primary Monocyte-Derived Macrophages Triggers the Production of Proinflammatory Mediators and Enhances Infection of Unactivated CD4 T |
| Q33895123 | Interactions between HIV-1 and the cell-autonomous innate immune system. |
| Q89527088 | Interference with HIV infection of the first cell is essential for viral clearance at sub-optimal levels of drug inhibition |
| Q60045088 | Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines |
| Q35909939 | Investigating the Consequences of Interference between Multiple CD8+ T Cell Escape Mutations in Early HIV Infection |
| Q34280115 | Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum |
| Q37971871 | Key Concepts in the Early Immunology of HIV-1 Infection |
| Q38998925 | Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies |
| Q30414086 | Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization |
| Q37362368 | Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection |
| Q34514374 | Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV |
| Q40118193 | Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens. |
| Q34792976 | Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection. |
| Q36246646 | Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants |
| Q92523449 | Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study |
| Q34802271 | Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users |
| Q34120840 | Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys |
| Q37273086 | Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. |
| Q37618276 | M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures |
| Q35746218 | MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model |
| Q34681455 | MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1. |
| Q34742795 | Macrophage infection via selective capture of HIV-1-infected CD4+ T cells |
| Q34931267 | Macrophages and Cell-Cell Spread of HIV-1. |
| Q36737917 | Macrophages sustain HIV replication in vivo independently of T cells |
| Q35589028 | Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints. |
| Q42638889 | Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity |
| Q33545560 | Mathematical modeling of ultradeep sequencing data reveals that acute CD8+ T-lymphocyte responses exert strong selective pressure in simian immunodeficiency virus-infected macaques but still fail to clear founder epitope sequences |
| Q28257799 | Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development |
| Q33753929 | Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex. |
| Q36215001 | Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication |
| Q26999403 | Microbicides: topical prevention against HIV |
| Q34047780 | Minority variants of drug-resistant HIV. |
| Q30992754 | Modelling the evolution and spread of HIV immune escape mutants |
| Q35102285 | Models for predicting effective HIV chemoprevention in women |
| Q42744934 | Modulation of HIV-1 macrophage-tropism among R5 envelopes occurs before detection of neutralizing antibodies |
| Q92340123 | Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models |
| Q40238313 | Molecular Features of the V1-V4 Coding Region of Sexually Transmitted Human Immunodeficiency Virus Type 1. |
| Q28601925 | Molecular clock of HIV-1 envelope genes under early immune selection |
| Q89575126 | Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand |
| Q38749319 | Molecular evolution analysis of the human immunodeficiency virus type 1 envelope in simian/human immunodeficiency virus-infected macaques: implications for challenge dose selection. |
| Q36532973 | Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones |
| Q37442115 | Molecular linkage tracing of HIV-1 transmission events in seroconcordant couples in Guangxi Province, Southeastern China |
| Q33900353 | Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection events |
| Q37555926 | Mucosal co-infections and HIV-1 transmission and pathogenesis |
| Q34275424 | Mucosal immunity in the female genital tract, HIV/AIDS |
| Q36957775 | Mucosal immunology of HIV infection |
| Q36559660 | Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus |
| Q36492916 | Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance |
| Q36676496 | Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencing |
| Q96585128 | MxB sensitivity of HIV-1 is determined by a highly variable and dynamic capsid surface |
| Q47141408 | Myeloid Cell Interaction with HIV: A Complex Relationship. |
| Q92325733 | N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation |
| Q27318354 | Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission |
| Q100946003 | Nanoscale flow cytometry reveals interpatient variability in HIV protease activity that correlates with viral infectivity and identifies drug-resistant viruses |
| Q36144358 | Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country |
| Q92239576 | Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1 |
| Q34304203 | Neutralisation of HIV-1 cell-cell spread by human and llama antibodies. |
| Q52660832 | Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones. |
| Q37252676 | Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge |
| Q34274849 | New approaches to design HIV-1 T-cell vaccines |
| Q33767191 | New directions for HIV vaccine development from animal models |
| Q56880081 | New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels |
| Q54250864 | Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center. |
| Q64106336 | Next-generation sequencing of HIV-1 single genome amplicons |
| Q47547864 | On the Demographic and Selective Forces Shaping Patterns of Human Cytomegalovirus Variation within Hosts |
| Q41144784 | Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function |
| Q59360836 | PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C |
| Q30376824 | Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin. |
| Q92327047 | Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1 |
| Q34614272 | Particle infectivity of HIV-1 full-length genome infectious molecular clones in a subtype C heterosexual transmission pair following high fidelity amplification and unbiased cloning |
| Q37528015 | Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose |
| Q36154787 | Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N. |
| Q39305961 | Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections |
| Q42680526 | Patterns and rates of viral evolution in HIV-1 subtype B infected females and males |
| Q36166932 | Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial |
| Q40464768 | Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305). |
| Q58572549 | Phenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute Infection |
| Q36281817 | Phenotypic Correlates of HIV-1 Macrophage Tropism |
| Q35192915 | Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins |
| Q34336058 | Phenotypic properties of transmitted founder HIV-1 |
| Q30404569 | Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants |
| Q58762598 | Phylogenetic approach to recover integration dates of latent HIV sequences within-host |
| Q37206422 | Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions |
| Q59355665 | Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants |
| Q36684805 | Phylogenetically resolving epidemiologic linkage. |
| Q34062554 | Picomolar dichotomous activity of gnidimacrin against HIV-1. |
| Q30514155 | Pilot studies for development of an HIV subtype panel for surveillance of global diversity |
| Q37062259 | Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment |
| Q45373420 | Pooled peripheral blood mononuclear cells provide an optimized cellular substrate for human immunodeficiency virus Type 1 isolation during acute infection. |
| Q36479690 | Population genomics of intrapatient HIV-1 evolution |
| Q37272324 | Postintegration HIV-1 infection of cervical epithelial cells mediates contact-dependent productive infection of T cells |
| Q34548621 | Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities |
| Q36305433 | Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions |
| Q38631923 | Primary infection by a human immunodeficiency virus with atypical coreceptor tropism |
| Q34535698 | Prospective cohort study of HIV incidence and molecular characteristics of HIV among men who have sex with men(MSM) in Yunnan Province, China |
| Q36318184 | Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir |
| Q37547061 | Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities |
| Q37123237 | Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners |
| Q33869259 | R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodes |
| Q37039116 | Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression |
| Q38849453 | Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection |
| Q30235024 | Recent Insights into the HIV/AIDS Pandemic |
| Q36286175 | Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission |
| Q35274968 | Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDS. |
| Q34269570 | Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection. |
| Q34858876 | Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies |
| Q28488527 | Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice |
| Q34042642 | Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections |
| Q33828583 | Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection |
| Q34243486 | Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation. |
| Q37532983 | Relative resistance of HIV-1 founder viruses to control by interferon-alpha |
| Q42208022 | Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants. |
| Q26767362 | Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence |
| Q34357068 | Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. |
| Q37359047 | Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction. |
| Q33961704 | Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use. |
| Q37612507 | Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness |
| Q33910862 | Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus |
| Q84366798 | Roadblocks in HIV research: five questions |
| Q38213061 | Role of Fc-mediated antibody function in protective immunity against HIV-1. |
| Q36290832 | Role of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection |
| Q27321665 | SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells |
| Q36146917 | SCOTTI: Efficient Reconstruction of Transmission within Outbreaks with the Structured Coalescent |
| Q35754196 | SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses |
| Q35581949 | SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma |
| Q40084752 | Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial |
| Q36184440 | Saturation Mutagenesis of the HIV-1 Envelope CD4 Binding Loop Reveals Residues Controlling Distinct Trimer Conformations |
| Q35763313 | Schistosoma mansoni Infection in Ugandan Men Is Associated with Increased Abundance and Function of HIV Target Cells in Blood, but Not the Foreskin: A Cross-sectional Study |
| Q55261162 | Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions. |
| Q34721189 | Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins |
| Q30354832 | Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses |
| Q34295695 | Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract |
| Q35018140 | Selective transmission of R5 HIV-1 variants: where is the gatekeeper? |
| Q92914545 | Selective transmission of some HIV-1 subtype C variants might depend on Envelope stimulating dendritic cells to secrete IL-10 |
| Q27331721 | Semen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaques |
| Q33390855 | Seminal plasma induces inflammation and enhances HIV-1 replication in human cervical tissue explants |
| Q37336742 | Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host |
| Q34291084 | Sequence evolution of HIV-1 following mother-to-child transmission |
| Q30407004 | Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection |
| Q37619686 | Serial cervicovaginal exposures with replication-deficient SIVsm induce higher dendritic cell (pDC) and CD4+ T-cell infiltrates not associated with prevention but a more severe SIVmac251 infection of rhesus macaques |
| Q92124025 | Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction |
| Q36756170 | Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues |
| Q42213317 | Short communication: HIV-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencing |
| Q28478624 | Significantly longer envelope V2 loops are characteristic of heterosexually transmitted subtype B HIV-1 in Trinidad |
| Q35232811 | Simple mathematical models do not accurately predict early SIV dynamics |
| Q41867747 | Single genome amplification and direct amplicon sequencing of Plasmodium spp. DNA from ape fecal specimens |
| Q33625191 | Single genome amplification of proviral HIV-1 DNA from dried blood spot specimens collected during early infant screening programs in Lusaka, Zambia |
| Q36433960 | Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification |
| Q35672336 | South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication |
| Q35925331 | Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection |
| Q37932048 | Specific microbicides in the prevention of HIV infection |
| Q40290521 | Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. |
| Q36053810 | Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses |
| Q33921277 | Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages |
| Q28749596 | Structure activity relationship of dendrimer microbicides with dual action antiviral activity |
| Q35099081 | Structured observations reveal slow HIV-1 CTL escape |
| Q37704735 | Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection |
| Q30238730 | Survivors Remorse: antibody-mediated protection against HIV-1. |
| Q59352769 | Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs |
| Q34762224 | Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones |
| Q88972036 | T cells establish and maintain CNS viral infection in HIV-infected humanized mice |
| Q33797892 | Taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of HIV-1 |
| Q35985519 | Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability |
| Q34451254 | Targeted deep sequencing of HIV-1 using the IonTorrentPGM platform |
| Q30386549 | Targeting early infection to prevent HIV-1 mucosal transmission. |
| Q30382590 | Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. |
| Q37707466 | The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block. |
| Q40091554 | The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards |
| Q42314454 | The HIV-1 transmission bottleneck |
| Q92881205 | The Impact of Cellular Proliferation on the HIV-1 Reservoir |
| Q64885907 | The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: in vitro and ex vivo Models. |
| Q59349051 | The Puzzle of HIV Neutral and Selective Evolution |
| Q27000032 | The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa |
| Q34642996 | The T-cell response to HIV. |
| Q40697873 | The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection |
| Q34427503 | The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis |
| Q34217360 | The colocalization potential of HIV-specific CD8+ and CD4+ T-cells is mediated by integrin β7 but not CCR6 and regulated by retinoic acid |
| Q30408103 | The development of an AIDS mucosal vaccine. |
| Q42593675 | The dynamics of HIV-1 adaptation in early infection. |
| Q37273195 | The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection |
| Q28541827 | The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates |
| Q41555215 | The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB. |
| Q34614862 | The immune response during acute HIV-1 infection: clues for vaccine development |
| Q37481983 | The intra-host evolutionary and population dynamics of human immunodeficiency virus type 1: a phylogenetic perspective |
| Q40144203 | The mutable vaccine for mutable viruses |
| Q37683788 | The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection |
| Q38021263 | The origin of genetic diversity in HIV-1. |
| Q35009308 | The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression |
| Q43576040 | The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors |
| Q37547702 | The selection of low envelope glycoprotein reactivity to soluble CD4 and cold during simian-human immunodeficiency virus infection of rhesus macaques. |
| Q36291699 | The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria |
| Q36846254 | Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire |
| Q34064859 | Timing and order of transmission events is not directly reflected in a pathogen phylogeny |
| Q33515034 | Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection |
| Q37089202 | Tissue-specific HIV-1 infection: why it matters |
| Q37233074 | Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs |
| Q54210802 | Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection. |
| Q42549345 | Tracking the culprit: HIV-1 evolution and immune selection revealed by single-genome amplification |
| Q35973063 | Transfer of Viral Communities between Human Individuals during Fecal Microbiota Transplantation |
| Q37464540 | Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences |
| Q33680395 | Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing |
| Q34874985 | Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients |
| Q40634933 | Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection |
| Q36607127 | Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. |
| Q36000722 | Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7 |
| Q34433975 | Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques |
| Q57295387 | Ultra-long-acting removable drug delivery system for HIV treatment and prevention |
| Q90196947 | Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery |
| Q36068841 | Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro |
| Q30421453 | Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes |
| Q92859937 | Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses |
| Q37395749 | Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes |
| Q26861425 | Using nonhuman primates to model HIV transmission |
| Q33778508 | Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells |
| Q37095477 | Vaginal concentrations of lactic acid potently inactivate HIV |
| Q58591002 | Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones |
| Q34170655 | Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis |
| Q34203163 | Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection |
| Q38739273 | Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication |
| Q36497283 | Vertical T cell immunodominance and epitope entropy determine HIV-1 escape |
| Q35593158 | Viral determinants of HIV-1 macrophage tropism |
| Q34270602 | Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection |
| Q33844706 | Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial |
| Q27013917 | Viral quasispecies evolution |
| Q39400038 | Virus-Host Gene Interactions Define HIV-1 Disease Progression. |
| Q35690771 | Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells |
| Q38936957 | Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages. |
| Q33877419 | Wide variation in the multiplicity of HIV-1 infection among injection drug users |
| Q33619649 | Within-Epitope Interactions Can Bias CTL Escape Estimation in Early HIV Infection |
Search more.